TABLE OF CONTENT: 1. Introduction 1.1. Research Scope 1.2. Market Segmentation 1.3. Research Methodology 1.4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. Key Insights 4.1. Mergers & Acquisitions Among Key Players 4.2. The Regulatory Scenario in Key Countries/Region 4.3. Competition Matrix for the Services Provided by Key Players. 5. Global Contract Research Organization Services Market Analysis, Insights and Forecast, 2015-2026 5.1. Key Findings / Summary 5.2. Market Analysis, Insights and Forecast – By Service Type 5.2.1. Discovery 5.2.2. Pre-Clinical 5.2.3. Clinical 5.2.4. Laboratory Services 5.3. Market Analysis, Insights and Forecast – By Application 5.3.1. Oncology 5.3.2. Cardiology 5.3.3. Infectious Disease 5.3.4. Metabolic Disorders 5.3.5. Others 5.4. Market Analysis, Insights and Forecast – By End User 5.4.1. Pharmaceutical & Biotechnological Companies 5.4.2. Medical Device Companies 5.4.3. Academic & Research Institutes 5.4.4. Others 5.5. Market Analysis, Insights and Forecast – By Region 5.5.1. North America 5.5.2. Europe 5.5.3. Asia pacific 5.5.4. Rest of the World 6. North America Contract Research Organization Services Market Analysis, Insights and Forecast, 2015-2026 6.1. Key Findings / Summary 6.2. Market Analysis – By Service Type 6.2.1. Discovery 6.2.2. Pre-Clinical 6.2.3. Clinical 6.2.4. Laboratory Services 6.3. Market Analysis – By Application 6.3.1. Oncology 6.3.2. Cardiology 6.3.3. Infectious Disease 6.3.4. Metabolic Disorders 6.3.5. Others 6.4. Market Analysis – By End User 6.4.1. Pharmaceutical & Biotechnological Companies 6.4.2. Medical Device Companies 6.4.3. Academic & Research Institutes 6.4.4. Others 6.5. Market Analysis – By Country 6.5.1. U.S. 6.5.2. Canada 7. Europe Contract Research Organization Services Market Analysis, Insights and Forecast, 2015-2026 7.1. Key Findings / Summary 7.2. Market Analysis – By Service Type 7.2.1. Discovery 7.2.2. Pre-Clinical 7.2.3. Clinical 7.2.4. Laboratory Services 7.3. Market Analysis – By Application 7.3.1. Oncology 7.3.2. Cardiology 7.3.3. Infectious Disease 7.3.4. Metabolic Disorders 7.3.5. Others 7.4. Market Analysis – By End User 7.4.1. Pharmaceutical & Biotechnological Companies 7.4.2. Medical Device Companies 7.4.3. Academic & Research Institutes 7.4.4. Others 7.5. Market Analysis – By Country/Sub-region 7.5.1. U.K. 7.5.2. Germany 7.5.3. France 7.5.4. Spain 7.5.5. Italy 7.5.6. Scandinavia 7.5.7. Rest of Europe 8. Asia pacific Contract Research Organization Services Market Analysis, Insights and Forecast, 2015-2026 8.1. Key Findings / Summary 8.2. Market Analysis – By Service Type 8.2.1. Discovery 8.2.2. Pre-Clinical 8.2.3. Clinical 8.2.4. Laboratory Services 8.3. Market Analysis – By Application 8.3.1. Oncology 8.3.2. Cardiology 8.3.3. Infectious Disease 8.3.4. Metabolic Disorders 8.3.5. Others 8.4. Market Analysis – By End User 8.4.1. Pharmaceutical & Biotechnological Companies 8.4.2. Medical Device Companies 8.4.3. Academic & Research Institutes 8.4.4. Others 8.5. Market Analysis – By Country/Sub-region 8.5.1. Japan 8.5.2. China 8.5.3. India 8.5.4. Australia 8.5.5. Southeast Asia 8.5.6. Rest of Asia Pacific 9. Rest of the World Contract Research Organization Services Market Analysis, Insights and Forecast, 2015-2026 9.1. Key Findings / Summary 9.2. Market Analysis – By Service Type 9.2.1. Discovery 9.2.2. Pre-Clinical 9.2.3. Clinical 9.2.4. Laboratory Services 9.3. Market Analysis – By Application 9.3.1. Oncology 9.3.2. Cardiology 9.3.3. Infectious Disease 9.3.4. Metabolic Disorders 9.3.5. Others 9.4. Market Analysis – By End User 9.4.1. Pharmaceutical & Biotechnological Companies 9.4.2. Medical Device Companies 9.4.3. Academic & Research Institutes 9.4.4. Others 10. Competitive Analysis 10.1. Key Industry Developments 10.2. Global Market Share Analysis (2018) 10.3. Competition Dashboard 10.4. Comparative Analysis – Major Players 10.5. Company Profiles 10.5.1. Pharmaceutical Product Development, LLC. 10.5.2. Medpace 10.5.3. Clintec 10.5.4. KCR S.A. 10.5.5. ICON plc 10.5.6. Parexel International Corporation 10.5.7. IQVIA 10.5.8. Covance Inc 10.5.9. Charles River 10.5.10. PSI 11. Strategic Recommendations

Pharmaceutical Product Development, LLC. Medpace Clintec IQVIA PRA Health Sciences, Inc. ICON plc KCR S.A. PSI Parexel International Corporation. Covance Inc. Other prominent players